Commitments and Contingencies - Additional Information (Detail) (USD $)	1 Months Ended	12 Months Ended		1 Months Ended	0 Months Ended		12 Months Ended					12 Months Ended
	Jan. 31, 2013	Dec. 31, 2013 sqft	Dec. 31, 2012	Jan. 31, 2014 Subsequent Event [Member]	Feb. 01, 2013 Boston Children's Hospital and Children's Medical Center Corporation [Member]	May 02, 2012 Biostorage Technologies, Inc [Member]	Dec. 31, 2013 Biostorage Technologies, Inc [Member] Installment	Jul. 27, 2013 Biostorage Technologies, Inc [Member]	Jul. 31, 2013 Biostorage Technologies, Inc [Member] Installment One [Member]	Dec. 31, 2013 Biostorage Technologies, Inc [Member] Installment Two [Member]	Feb. 28, 2014 Biostorage Technologies, Inc [Member] Subsequent Event [Member] Installment Three [Member]	Dec. 31, 2013 BCH and CMCC [Member]
Loss Contingencies [Line Items]
Area of office space		200
Total rent expense		$ 25,800	$ 71,500
Rent expenses		4,141,300
Rent expense in auburndale		500
Rent expenses		2,500
Amount claimed					642,906	119,363						(185,000)
Shares received against execution of sublicense granted												20,000
Amount claimed				40,000			95,000
Number of share		20,000
Value of common stock		40,000
Agreement amount								75,000	10,000	40,000	25,000
Number of installments							3
Gain (loss) related to litigation settlement							20,000
Judgment vacated date							Feb. 28, 2014
Notice days for breach remains uncured		60 days
License agreements towards Harvard License Agreements		8,750
Sublicense execution payment		175,000
Period for cash payment to Harvard due, following the first commercial sale of Altropane product		30 days
Stock received as part of the sublicense agreement	15,000	5,000	15,000
Company is obligated to transfer shares of the Navidea common stock received by the Company		5,000
Agreed Payment on option agreement		10,000
Payment on option agreement		$ 200,000